Australia markets closed

Firebrick Pharma Limited (FRE.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.05300.0000 (0.00%)
At close: 02:05PM AEST
Currency in AUD

Valuation measures4

Market cap (intra-day) 9.48M
Enterprise value 8.18M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.13
Price/book (mrq)5.97
Enterprise value/revenue 4.56
Enterprise value/EBITDA -1.77

Trading information

Stock price history

Beta (5Y monthly) 1.82
52-week change 3-72.82%
S&P500 52-week change 323.42%
52-week high 30.3600
52-week low 30.0360
50-day moving average 30.0518
200-day moving average 30.0968

Share statistics

Avg vol (3-month) 3107.06k
Avg vol (10-day) 3164.41k
Shares outstanding 5178.95M
Implied shares outstanding 6178.95M
Float 889.65M
% held by insiders 150.49%
% held by institutions 10.66%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -251.57%
Operating margin (ttm)-48.02%

Management effectiveness

Return on assets (ttm)-74.49%
Return on equity (ttm)-136.04%

Income statement

Revenue (ttm)1.82M
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)7,953.80%
Gross profit (ttm)N/A
EBITDA -4.5M
Net income avi to common (ttm)-4.57M
Diluted EPS (ttm)-0.0300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.31M
Total cash per share (mrq)0.01
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)5.17
Book value per share (mrq)0.01

Cash flow statement

Operating cash flow (ttm)-4.6M
Levered free cash flow (ttm)-3.14M